Slide 1MODELS OF SYSTEMIC TREATMENT IN BREAST CANCER EMRA against cancer 1 st Forum NGOs and cancer: Challenges and opportunities NGOs and cancer: Challenges and opportunities…
1. Rituximab monotherapy in FLJeff Sharman M.D.Willamette Valley Cancer Center Eugene OregonMedical Director Hematology Research US Oncology 2. Low Tumor Burden
A Phase III Randomized Intergroup Trial (SWOG S0016) of CHOP Chemotherapy plus Rituximab vs CHOP Chemotherapy plus Iodine-131-Tositumomab for the Treatment of Newly Diagnosed…